Navigation Links
Parkinson's Disrupts Stem Cell Therapy Transplants
Date:4/6/2008

Dopamine neurons may not work long-term, as disease causes pathologic changes in cells

SUNDAY, April 6 (HealthDay News) -- Current therapies using stem cell transplants in the brains of patients with Parkinson's disease may not work long-term, because the disease is an ongoing process that continually causes damage, new findings suggest.

Dopamine cells are sometimes transplanted into the brain of Parkinson's patients in the hope that they can replace those neurons that have degenerated. In theory, this should improve the disease's symptoms, which include tremors, stiffness of the limbs and trunk, slowed movement and impaired balance and coordination.

Researchers at Mount Sinai School of Medicine in New York City and Rush University Medical Center in Chicago studied brain tissue from a patient who had received a dopamine transplant 14 years earlier and found that the transplanted cells developed changes characteristic of Parkinson's disease (PD) and did not appear to function normally.

The patient had improved initially after the transplant but then deteriorated, noted the study, published in the April issue of Nature Medicine.

"While, on the one hand, these results may sound disappointing, this information is crucially important if we are to develop better therapies for PD. The more knowledge we gain about the nature of the disease, the better our chances to find the cause of why cells degenerate and to develop a treatment that can protect them," Dr. C. Warren Olanow, director of the Robert and John M. Bendheim Parkinson's Disease Center at Mount Sinai School of Medicine, said in a prepared statement. "These findings also do not mean that transplant strategies such as stem cells cannot be made to work -- our findings just represent another obstacle that will have to be overcome."

According to researchers, these new findings counter the theory that a single event, like an infection, causes the initial damage to cells and triggers their gradual degeneration over time. Since the newly implanted cells in the Parkinson's patient also became damaged, they suggest that the disease process is ongoing.

More information

The National Institute of Neurological Disorders and Stroke has more about Parkinson's disease.



-- Kevin McKeever



SOURCE: Mount Sinai Medical Center, news release, April 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. How DDT metabolite disrupts breast cancer cells
2. Antibacterial chemical disrupts hormone activities
3. Nicotine in breast milk disrupts infants sleep patterns
4. Occupational Therapy Month 2008 Highlights Profession as Career Choice
5. SEISMIC study issues glum report on cell therapy
6. 2-drug blood pressure therapy lowers cardiovascular risk
7. Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
8. BioLife Solutions Expands Presence in Cell Therapy and Cord Blood Banking Market Segments
9. Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care
10. Drug Therapy Boosting Heart-Attack Survival Rates
11. ClearScript Offers Innovative Medication Therapy Management Program to Employee Health Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Groth Family Insurance, a Washington-based ... is initiating a charity drive to support the family of Cindy Hendrickson, a ... , On October 29th of this year, Cindy Hendrickson swerved to avoid ...
(Date:12/9/2016)... ... 09, 2016 , ... The Justin Veatch Fund announced Thursday that ... the film Whispering Spirits and its discussion guide for use by all ... tool in the war against teen drug abuse. NCADD is the oldest anti-addiction ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Insights beginning January 1, 2017. The name change aligns the entire company ... and improving health care quality. , “We are very proud of the achievements ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic ... Informatics . , Results of the comparative usability study demonstrate that a dictation-based ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... vaccines market to grow at a CAGR of 6.83% during the ... the growth prospects of the global travel vaccines market for 2016-2020. ... from the sales of various vaccines administered to actively immunize meningococcal ...
(Date:12/8/2016)... 2016 IRIDEX Corporation (NASDAQ: IRIX ) ... of common stock, $0.01 par value (the "Offering" with such ...  The final terms of the Offering will depend on market ... can be no assurance as to whether or when the ... the net proceeds it will receive from this offering for ...
Breaking Medicine Technology: